Article List

WPRIM Management System> DCMS> Kidney Research and Clinical Practice> 2017> 36> 4

Volume: 36 Issue: 4

1. Unilateral renal atrophy associated with abdominal aortic aneurysm.	Page:394—395
2. Type 1 primary hyperoxaluria in a male infant.	Page:393—393
3. Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy.	Page:387—392
4. Changes in geriatric nutritional risk index and risk of major adverse cardiac and cerebrovascular events in incident peritoneal dialysis patients.	Page:377—386
5. Relationship between serum uric acid and mortality among hemodialysis patients: Retrospective analysis of Korean end-stage renal disease registry data.	Page:368—376
6. Prognostic performance of combined use of high-sensitivity troponin T and creatine kinase MB isoenzyme in high cardiovascular risk patients with end-stage renal disease.	Page:358—367
7. Physician perceptions of blood pressure control in patients with chronic kidney disease and target blood pressure achievement rate.	Page:349—357
8. Cockcroft-Gault, Modification of Diet in Renal Disease, and Chronic Kidney Disease Epidemiology Collaboration equations for estimating glomerular filtration rates in cancer patients receiving cisplatin-based chemotherapy.	Page:342—348
9. Active maintenance of endothelial cells prevents kidney fibrosis.	Page:329—341
10. Maturation of arteriovenous fistula: Analysis of key factors.	Page:318—328
11. Renal intercalated cells and blood pressure regulation.	Page:305—317
12. Serum uric acid and mortality risk among maintenance hemodialysis patients.	Page:302—304
13. Active maintenance of endothelial cells prevents kidney fibrosis.	Page:329—341
14. Epoxyeicosatrienoic acid activation moderates endothelial mesenchymal transition to reduce obstructive nephropathy.	Page:299—301
15. Maturation of arteriovenous fistula: Analysis of key factors.	Page:318—328
16. Renal intercalated cells and blood pressure regulation.	Page:305—317
17. Serum uric acid and mortality risk among maintenance hemodialysis patients.	Page:302—304
18. Epoxyeicosatrienoic acid activation moderates endothelial mesenchymal transition to reduce obstructive nephropathy.	Page:299—301